Ineffectiveness of topoisomerase mutations in mediating clinically significant fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB efflux pump.
about
Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistanceCo-Selection of Resistance to Antibiotics, Biocides and Heavy Metals, and Its Relevance to Foodborne PathogensPresence of multidrug-resistant enteric bacteria in dairy farm topsoilTriclosan: current status, occurrence, environmental risks and bioaccumulation potentialA Transporter Interactome Is Essential for the Acquisition of Antimicrobial Resistance to AntibioticsEfflux-mediated heavy metal resistance in prokaryotes.A 96-well plate fluorescence assay for assessment of cellular permeability and active efflux in Salmonella enterica serovar Typhimurium and Escherichia coli.Constitutive SoxS expression in a fluoroquinolone-resistant strain with a truncated SoxR protein and identification of a new member of the marA-soxS-rob regulon, mdtGDifferent effects of transcriptional regulators MarA, SoxS and Rob on susceptibility of Escherichia coli to cationic antimicrobial peptides (CAMPs): Rob-dependent CAMP induction of the marRAB operon.The prevalence of fluoroquinolone resistance mechanisms in colonizing Escherichia coli isolates recovered from hospitalized patientsGenetic characterization of highly fluoroquinolone-resistant clinical Escherichia coli strains from China: role of acrR mutations.Efflux-mediated resistance to fluoroquinolones in gram-negative bacteriamar Operon involved in multidrug resistance of Enterobacter aerogenes.Role of active efflux in association with target gene mutations in fluoroquinolone resistance in clinical isolates of Vibrio cholerae.Overcoming antimicrobial resistance by targeting resistance mechanisms.Mechanism of action of and resistance to quinolones.Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteriaPatterns of resistance associated with integrons, the extended-spectrum beta-lactamase SHV-5 gene, and a multidrug efflux pump of Klebsiella pneumoniae causing a nosocomial outbreakMarA-like regulator of multidrug resistance in Yersinia pestis.Antimicrobials: modes of action and mechanisms of resistance.Role of AcrR and ramA in fluoroquinolone resistance in clinical Klebsiella pneumoniae isolates from Singapore.Increased genome instability in Escherichia coli lon mutants: relation to emergence of multiple-antibiotic-resistant (Mar) mutants caused by insertion sequence elements and large tandem genomic amplifications.New advances in antibiotic development and discovery.The quinolones: past, present, and future.Mechanisms of resistance to quinolones.Characterization of two HIV-1 infectors during initial antiretroviral treatment, and the emergence of phenotypic resistance in reverse transcriptase-associated mutation patterns.Global fluoroquinolone resistance epidemiology and implictions for clinical use.Multidrug-resistance efflux pumps - not just for resistance.Resistance to Fluoroquinolone by a Combination of Efflux and Target Site Mutations in Enteroaggregative Escherichia coli Isolated in Korea.Drug efflux pump deficiency and drug target resistance masking in growing bacteriaDevelopment and validation of a diagnostic DNA microarray to detect quinolone-resistant Escherichia coli among clinical isolates.AcrAB-TolC directs efflux-mediated multidrug resistance in Salmonella enterica serovar typhimurium DT104.Efflux pump-mediated resistance in chemotherapy.Multidrug efflux pumps in Gram-negative bacteria and their role in antibiotic resistance.Efflux pump induction by quaternary ammonium compounds and fluoroquinolone resistance in bacteria.Mechanisms of fluoroquinolone resistance in Escherichia coli isolates from food-producing animals.Antibiotics and the Intestinal Microbiome : Individual Responses, Resilience of the Ecosystem, and the Susceptibility to Infections.Escherichia coli mar and acrAB mutants display no tolerance to simple alcohols.In vivo increase in resistance to ciprofloxacin in Escherichia coli associated with deletion of the C-terminal part of MarRHigh-level fluoroquinolone-resistant clinical isolates of Escherichia coli overproduce multidrug efflux protein AcrA.
P2860
Q24548472-4909B072-F9D1-46A0-8D63-C1B14FCAC8D5Q27010252-E40D1963-FDF4-4F8B-9094-2132819BD191Q28210883-6E1BCA62-59E4-41AF-BD47-185AA2FF40E7Q28395589-7D200123-453F-4135-91AB-2430156CF977Q28551202-2EAEA1F4-78E1-48AF-8049-6D964ED2193FQ30320564-66246B08-6BFE-41F3-B1EF-5B8357632D65Q33591125-A94105F8-D3D3-41C2-B33B-B6C29A192E5FQ33676174-BFD774E4-CA73-42D3-975F-2734626C2D95Q33931546-A387392B-8500-4382-8364-8871922E5F8DQ33964949-6741CB97-E565-4169-B09E-34369C423BA7Q33982113-63DDB7CF-B07E-40AB-8B00-E26473C18F9CQ34010692-313ED890-6B83-46CC-98F1-4CC9A5C906B9Q34106009-8AB3F8D6-E1CF-49CD-BF31-96255E23E8BFQ34111663-BA05B0D6-3214-469B-B9D7-ABF574A70B2CQ34211132-5B05B152-4899-4644-AC8A-7DE199A37FE6Q34408434-C0C32EE4-213F-410C-B468-42C4DE167995Q34647294-81335118-65F2-4E36-BDFB-3A0606C19976Q34772652-A8D1160E-ED01-4D25-BE2C-BC1C6B3E4D34Q35023363-954406D7-2848-42D7-9E44-36F7468C53ECQ35127138-141BF1F1-BA97-4AE9-8BDD-EEF1D8873EC2Q35685143-5BAE1337-8C64-4AB1-8FC6-525B155FD918Q35758863-AEDEBA43-72FF-433C-AD43-0D3F1AC78CE9Q36065983-5774B137-1F05-46B9-90CA-8236E252B275Q36155438-7CAF158A-932D-45C9-80DC-9926BDF000D6Q36155441-7B0D99F6-A5C5-4382-971A-9C7EA0889631Q36292765-9200E0DB-43BC-4195-A5B7-F19E75BB9E34Q36337074-DC4FDE04-7520-4AA7-873C-1F709A9B0174Q36538111-0089BF4D-BDEA-4865-B02C-C12CAA6EDFD9Q37105865-9092A0FB-A474-44D3-B08D-E4A0A4DB7A21Q37208522-63DD084D-228F-4906-951B-E084F4D17F02Q37511160-21253FA5-3A8A-4474-B9E3-3FD56C78E6ECQ37568948-566B4E49-646A-470A-BB2D-F747935C776DQ38084554-42EC6B0C-CCF0-4AC8-ABC1-1D17B14DCC22Q38269145-20EF4E1A-3EF6-4D87-95B5-3652D93A67F9Q38671076-83F34577-E064-4070-BE51-80523FA2BDC7Q38724103-C758B985-BB80-4D1F-B4C2-D2B078BC74ABQ38980008-53349215-6D41-4EBF-8BC5-EE38672F12ECQ39282904-8720C11A-F47A-42FE-B3D0-CD1B04774C36Q39474394-31672FCF-4434-421F-B74D-8C1E5B1EB44BQ39475770-68083C9C-9AB7-4D6E-AC61-00603A706C83
P2860
Ineffectiveness of topoisomerase mutations in mediating clinically significant fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB efflux pump.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Ineffectiveness of topoisomera ...... ence of the AcrAB efflux pump.
@ast
Ineffectiveness of topoisomera ...... ence of the AcrAB efflux pump.
@en
type
label
Ineffectiveness of topoisomera ...... ence of the AcrAB efflux pump.
@ast
Ineffectiveness of topoisomera ...... ence of the AcrAB efflux pump.
@en
prefLabel
Ineffectiveness of topoisomera ...... ence of the AcrAB efflux pump.
@ast
Ineffectiveness of topoisomera ...... ence of the AcrAB efflux pump.
@en
P2093
P2860
P1476
Ineffectiveness of topoisomera ...... ence of the AcrAB efflux pump.
@en
P2093
A S Jellen-Ritter
L M McMurry
M Oethinger
P2860
P356
10.1128/AAC.44.1.10-13.2000
P407
P577
2000-01-01T00:00:00Z